Page 391 - Binder2

• Can value-based care replace volume-based billing?
Payers and providers must evolve toward a model that
rewards results, not procedures. That means:

• Reimbursing for durable remission.
• Incentivizing immune stabilization, not constant
escalation.
• Measuring success in years of wellness, not in units
of service.

• Will payers reimburse for time, insight, and immune
education instead of administration?
If the physician becomes an immune strategist rather than
an administrator, their value lies in guidance, interpretation,
and long-term planning. But those services—historically
labeled “non-billable cognitive labor”—must now be
compensated fairly.

• Can specialists reorient around outcomes—not
interventions?
The biologic specialist of the edible era will:

• Spend more time explaining mechanisms than
managing acute reactions.
• Help patients understand the arc of immune
reprogramming rather than chasing symptom
flares.
• Track and optimize long-term biological harmony,
not just suppress short-term inflammation.

Resistance and Reinvention

Not all practices will welcome this shift. Some will:

389